Bill > HR2003

This bill, titled the Gluten in Medicine Disclosure Act of 2013, aims to amend the Federal Food, Drug, and Cosmetic Act, which is the primary law governing the safety and labeling of food, drugs, and cosmetics in the United States. Specifically, it proposes that the labels of all drugs intended for human use must include a parenthetical statement identifying the source of any ingredient that is made from or derived from a grain or starch. This means that if a medication contains an ingredient that comes from wheat, corn, or other grains or starches (excluding certain types of sugar alcohols called polyols), the label will need to clearly state where that ingredient originated. This change is intended to provide consumers with more information about the composition of their medications, particularly for individuals who need to avoid gluten or other grain-derived ingredients for health reasons. The new labeling requirement will become effective on a date determined by the Secretary of Health and Human Services, or two years after the bill is enacted, whichever comes first.